NASDAQ: SMMT - Summit Therapeutics Inc.

Lønnsomhet i seks måneder: +86.41%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Summit Therapeutics Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Summit Therapeutics Inc.

Summit Therapeutics Inc., биофармацевтическая компания, занимается исследованиями и разработками в основном в области лечения онкологических заболеваний в США и Великобритании. Ассортимент продукции компании включает SMT-738, новый класс прецизионных антибиотиков для лечения, который находится на доклинической стадии для лечения инфекций с множественной лекарственной устойчивостью, которые в первую очередь включают инфекции Enterobacteriaceae, устойчивые к карбапенемам. Он имеет сотрудничество и лицензионное соглашение с Akeso, Inc.

flere detaljer
для исследования и разработки Ivonescimab (AK112) и SMT112, биспецифического антитела для иммунотерапии посредством блокады PD-1 с антиангиогенезом. Компания была основана в 2003 году и имеет штаб-квартиру в Кембридже, штат Массачусетс.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2015-03-05
ISIN US86627T1088
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.summittxinc.com
Цена ао 18.18
Prisendring per dag: 0% (18.175)
Prisendring per uke: +0.0826% (18.16)
Prisendring per måned: +1.93% (17.83)
Prisendring over 3 måneder: -16.78% (21.84)
Prisendring over seks måneder: +86.41% (9.75)
Prisendring per år: +425.29% (3.46)
Prisendring over 3 år: +580.71% (2.67)
Prisendring over 5 år: +1 087.99% (1.5299)
Prisendring over 10 år: 0% (18.175)
Prisendring siden begynnelsen av året: -9.13% (20)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 790.91 1
P/BV 18.9 1
P/E 0 0
EV/EBITDA -17.14 0
Total: 2.13

Effektivitet

Navn Betydning Karakter
ROA, % -303 0
ROE, % -791.49 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -1.17 10
Total: 7.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % -98.82 0
Lønnsomhet Ebitda, % 165.29 10
Lønnsomhet EPS, % 7533.85 10
Total: 8
Flere detaljer

Institusjoner Volum Dele, %
Blackrock Inc. 9759383 1.39
Vanguard Group Inc 7014982 1
Geode Capital Management, LLC 3085666 0.44
State Street Corporation 2456168 0.35
Northern Trust Corporation 1108089 0.16
Charles Schwab Investment Management, Inc. 953846 0.14
Morgan Stanley 704272 0.1
Steward Partners Investment Advisory, LLC 600000 0.09
Nuveen Asset Management, LLC 565624 0.08
Alps Advisors Inc. 532406 0.08

ETF Dele, % Lønnsomhet for året, % Utbytte, %
Range Cancer Therapeutics ETF 7.06601 47.24 0.11955
Virtus LifeSci Biotech Clinical Trials ETF 2.38708 63.04 0.33
Future Tech ETF 1.71443 426.34 0.8416
Principal Healthcare Innovators ETF 1.71443 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 1.578 28.58 0.8565
First Trust Small Cap Growth AlphaDEX Fund 1.41665 42.5 1.22182
ProShares Ultra Nasdaq Biotechnology 1.14553 51.7 0.85651
FlexShares US Quality Low Volatility Index Fund 0.7321 24.02 1.89656
First Trust Small Cap Core AlphaDEX Fund 0.50882 17.31 1.87983
Vanguard U.S. Momentum Factor ETF 0.4 30.05 1.05834
Direxion Daily S&P Biotech Bull 3x Shares 0.34334 4067.92 0.25924
First Trust Multi Cap Growth AlphaDEX Fund 0.28183 41.56 1.02425
Principal U.S. Small-Cap ETF 0.23117 16.7 1.20466
iShares Russell 2000 Growth ETF 0.14964 38.04 0.6026
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.12563 24.75 1.59225
Schwab U.S. Small-Cap ETF 0.09994 17.47 1.51433
Vanguard Russell 2000 Growth ETF 0.08 23.05 0.60264
BNY Mellon US Small Cap Core Equity ETF 0.05524 30.07 1.75333
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.05509 31.36 1.41955
ProShares UltraPro Russell2000 0.04613 89.82 1.47873
iShares Morningstar Small-Cap Growth ETF 0.04561 587.89 0.72598
iShares Morningstar Small-Cap Growth ETF 0.04561 33.63 0.72598
iShares Morningstar Small Cap Value ETF 0.04402 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.04402 201.65 2.50476
iShares Morningstar Small-Cap ETF 0.04321 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.04321 391.25 1.60498
Vanguard Russell 2000 ETF 0.04 17.16 1.48801
Humankind US Stock ETF 0.03183 18.81 1.99919
Vanguard Small Cap Value ETF 0.02 17.27 2.19419
ProShares Hedge Replication ETF 0.01311 5.92 1.47892
John Hancock Multifactor Mid Cap ETF 0.00806 20.65 1.52586
Schwab U.S. Broad Market ETF 0.00765 24.86 1.43354
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00676 21.94 1.69572
iShares Russell 3000 ETF 0.00385 24.83 1.43482
Avantis U.S. Large Cap Value ETF 0.00213 27.85 2.05311
John Hancock Multifactor Large Cap ETF 0.00171 21.77 1.59539
Dimensional U.S. Equity ETF 0.00048 31.53 1.3557
Avantis U.S. Equity ETF 0.00032 23.04 1.59151
Vanguard Russell 3000 ETF 0 31.87 1.43817



Veileder Stillingstittel Betaling Fødselsår
Mr. Robert W. Duggan Co-CEO & Executive Chairman N/A 1944 (81 år)
Prof. Dame Kay Davies DBE, FRS CBE Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor N/A 1951 (74 år)
Ms. Abby Guzman Murphy Head of Human Resources N/A
Ms. Divya Chari Head of Global Clinical Operations N/A 1968 (57 år)
Mr. Dave Gancarz Chief Business & Strategy Officer N/A
Dr. Mahkam Zanganeh D.D.S., M.B.A. Co-CEO, President & Director 657.81k 1970 (55 år)
Mr. Manmeet Singh Soni COO, CFO & Director 591.5k 1978 (47 år)
Dr. Betty Y. Chang Ph.D. Head of Research, Oncology & Inflammation N/A
Mr. Bhaskar Anand Chief Accounting Officer & Head of Finance 1978 (47 år)
Dr. Fong Clow Chief Biometrics Officer

Adresse: United States, Cambridge. MA, 2882 Sand Hill Road. Suite 106 - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.summittxinc.com